Loading…
.jpg)
Nordic Nanovector ASA and Thor Medical AS entered into a definitive share exchange agreement for an all-share transaction. The combined company will focus on radionuclide production for cancer treatment, with Scatec Innovation becoming the largest shareholder.
“The acquisition of Thor Medical is an important strategic step for Nordic Nanovector”thormedical.com
Summarized from public sources; check the original articles before acting on it.